Levosimendan Use Increases Cardiac Performance after Coronary Artery Bypass Grafting in End-Stage Renal Disease Patients


Atalay H., Temizturk Z., Altinsoy H. B. , Azboy D., Colak S., Atalay A., ...More

HEART SURGERY FORUM, vol.19, no.5, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 5
  • Publication Date: 2016
  • Doi Number: 10.1532/hsf.1426
  • Title of Journal : HEART SURGERY FORUM

Abstract

Background: The effect of levosimendan on myocardial performance has not been studied in dialysis-dependent end-stage renal disease patients who have undergone coronary artery bypass grafting (CABG) surgery. Our aim was to investigate the effect of levosimendan on postoperative hemodynamic effects in end-stage renal disease patients undergoing CABG operation.